Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 25 peer-reviewed journal articles Updated
Maternal-Fetal Medicine

Why Do I Need an Amniocentesis for Hydrops Fetalis?

At a Glance

An ultrasound shows the fluid buildup of non-immune hydrops fetalis, but it cannot identify the underlying cause. An amniocentesis is required to test for the rare genetic conditions or viral infections causing the hydrops, which is essential for determining the right treatment for your baby.

When an ultrasound reveals non-immune hydrops fetalis (NIHF), it can be incredibly overwhelming. A common and completely understandable question is: If the ultrasound already shows the fluid buildup, why do I still need an invasive test like an amniocentesis? The short answer is that an ultrasound only diagnoses the symptom—the fluid itself—but it cannot tell your medical team why the fluid is accumulating [1][2]. An amniocentesis is required to retrieve fetal DNA and test for viruses, allowing doctors to run advanced tests that uncover the underlying cause [3][4]. Knowing this specific cause is what ultimately dictates your baby’s treatment options and prognosis [5][3].

Diagnosing the Cause vs. Seeing the Symptom

Think of hydrops fetalis like a severe fever; the fever tells you someone is sick, but it doesn’t tell you if they have a virus, a bacterial infection, or a genetic condition. Ultrasound imaging is an essential first step, but it often fails to detect the underlying genetic, metabolic, or rare infectious disorders responsible for the condition [1][6]. While sometimes an ultrasound can spot structural issues (like a heart defect), many conditions that cause hydrops present with fluid buildup and no other prenatally detectable physical anomalies [7][8].

You might wonder why a simple maternal blood draw—often called Non-Invasive Prenatal Testing (NIPT)—isn’t enough. NIPT is an excellent screening tool for common chromosomal issues, but it cannot diagnose the complex, rare genetic conditions or viral infections that frequently cause hydrops [9][10]. Without an amniocentesis, many cases of NIHF remain “idiopathic” (unexplained), leaving doctors guessing about the best way to help your baby [1].

Understanding the Procedure and Its Risks

An amniocentesis involves a doctor using continuous ultrasound guidance to safely insert a very thin needle through your abdomen and into the uterus to collect a small amount of amniotic fluid [3][11]. Alongside the amniocentesis, your blood will likely also be drawn to check for maternal factors contributing to the hydrops.

It is completely normal to be terrified of anything that might harm your already vulnerable baby. The primary risk associated with an amniocentesis is a small chance of complications, such as miscarriage or premature water breaking. However, in cases of hydrops fetalis, this procedural risk must be weighed against the severe risk of leaving the cause of the life-threatening fluid buildup undiagnosed and untreated.

The Tests Run on Amniotic Fluid and Timelines

Once the fluid is collected, the laboratory can perform several levels of testing to find the root cause of the hydrops [12]. Doctors often order these tests simultaneously to get answers as quickly as possible:

  • Infection Panels (PCR): The fluid is tested for congenital infections like Parvovirus B19, Cytomegalovirus (CMV), or syphilis [13][14]. These are critical to rule out because they are often highly treatable. Results usually return in a few days.
  • Karyotype: This is a broad overview of the baby’s chromosomes, looking for large structural changes or abnormal numbers [15][16]. Results typically take 1 to 2 weeks.
  • Chromosomal Microarray (CMA): This test acts like a higher-resolution magnifying glass. It looks for copy-number variants (CNVs)—smaller missing or extra pieces of DNA that a traditional karyotype might miss [15][17]. Results often take 1 to 2 weeks.
  • Whole Exome Sequencing (WES): If initial tests are normal, WES reads the exact “spelling” of individual genes to find rare, single-gene (monogenic) disorders, such as RASopathies or metabolic conditions [18][19][2]. Traditional WES can take several weeks, but many hospitals now use rapid WES (rWES) for severely ill babies, which can return answers in 1 to 2 weeks [20][21].

How This Changes Treatment and Prognosis

Discovering the exact cause directly impacts action. Identifying a specific etiology allows your care team to:

  • Tailor Treatment: Certain causes of hydrops have highly specific treatments. For example, if the amniocentesis reveals Parvovirus B19 or a genetic condition causing severe fetal anemia (like alpha-thalassemia), doctors can perform life-saving in-utero blood transfusions [22][23]. Other conditions might require fluid-draining shunts or aggressive specialized care immediately after birth.
  • Provide an Accurate Prognosis: Survival rates for NIHF vary dramatically depending on the cause. A precise diagnosis gives families a realistic understanding of what to expect, allowing for informed, compassionate decisions regarding pregnancy management, targeted interventions, or palliative care [3][24].
  • Understand Future Risks: Finding the specific genetic mutation helps doctors calculate the recurrence risk for future pregnancies and provides vital information for genetic counseling [4][25].

While the idea of an amniocentesis can be frightening, it is the crucial bridge between knowing your baby is sick and knowing exactly how to care for them.

Common questions in this guide

Why isn't a maternal blood draw (NIPT) enough to diagnose hydrops fetalis?
While NIPT is an excellent screening tool for common chromosomal issues, it cannot diagnose the complex, rare genetic conditions or viral infections that frequently cause hydrops fetalis. An amniocentesis is required to retrieve fetal DNA to uncover these specific causes.
What tests are performed on the amniotic fluid for hydrops?
Doctors test the amniotic fluid for infections like Parvovirus B19 and CMV, and perform genetic tests including a karyotype, chromosomal microarray, and whole exome sequencing. These tests work together to pinpoint the exact underlying cause of the fluid buildup.
How long does it take to get genetic test results from an amniocentesis?
Infection panels usually return in a few days. Standard genetic tests like karyotypes and microarrays typically take one to two weeks. If rapid whole exome sequencing is used, those advanced results can also be available in one to two weeks.
How does knowing the cause of hydrops change the treatment plan?
Finding the exact cause allows doctors to tailor treatments specifically for your baby. For example, if a viral infection or severe anemia is found, doctors can perform life-saving in-utero blood transfusions before birth.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is the expected turnaround time for the different genetic tests (Karyotype, CMA, WES) at this facility, and do you offer rapid WES?
  2. 2.Are you testing the amniotic fluid for infections like Parvovirus B19 and CMV in addition to genetic conditions?
  3. 3.What are the specific risks of performing an amniocentesis in my individual case, considering my current fluid levels?
  4. 4.How will the specific results of these genetic tests alter our immediate delivery plan or the choice of NICU level?
  5. 5.Will this testing automatically screen for conditions that we have a known family history of?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

Can Maternal Viral Infections Cause Hydrops Fetalis?Can Non-Immune Hydrops Fetalis Resolve on Its Own?Does Non-Immune Hydrops Fetalis Cause Premature Birth?How Are Fetal Arrhythmias Causing Hydrops Treated?How Are Intrauterine Blood Transfusions for Hydrops Done?What Are Long-Term Outcomes for NIHF Survivors?What Are the Symptoms of Mirror Syndrome vs Normal Swelling?What Does Idiopathic Non-Immune Hydrops Fetalis Mean?What Is a Thoracoamniotic Shunt for Fetal Hydrops?Immune vs. Non-Immune Hydrops: What Is the Difference?Will Non-Immune Hydrops Fetalis Happen Again?Why Do I Need Perinatal Palliative Care for NIHF?What to Expect Delivering a Baby With Hydrops Fetalis?Why Use Whole Exome Sequencing for Hydrops Fetalis?

References

References (25)
  1. 1

    Nonimmune hydrops fetalis management from the perspective of fetal cardiologists: A single tertiary center experience from Egypt.

    Rakha S, Elmarsafawy H

    Journal of neonatal-perinatal medicine 2021; (14(2)):237-244 doi:10.3233/NPM-200491.

    PMID: 33074198
  2. 2

    A systematic review of monogenic etiologies of nonimmune hydrops fetalis.

    Quinn AM, Valcarcel BN, Makhamreh MM, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2021; (23(1)):3-12 doi:10.1038/s41436-020-00967-0.

    PMID: 33082562
  3. 3

    Case Report: Whole Exome Sequencing Revealed Two Novel Mutations of PIEZO1 Implicated in Nonimmune Hydrops Fetalis.

    Chen Y, Jiang Y, Chen B, et al.

    Frontiers in genetics 2021; (12()):684555 doi:10.3389/fgene.2021.684555.

    PMID: 34421994
  4. 4

    Value of Exome Sequencing in Diagnosis and Management of Recurrent Non-immune Hydrops Fetalis: A Retrospective Analysis.

    Zhou X, Zhou J, Wei X, et al.

    Frontiers in genetics 2021; (12()):616392 doi:10.3389/fgene.2021.616392.

    PMID: 33897756
  5. 5

    Spontaneous resolution of nonimmune hydrops fetalis in a fetus with TP63 gene mutation and LZTR1 gene variants.

    Hurni Y, Marangoni M, Garofalo G, et al.

    Clinical case reports 2021; (9(8)):e04624 doi:10.1002/ccr3.4624.

    PMID: 34401172
  6. 6

    A single center experience in 90 cases with nonimmune hydrops fetalis: diagnostic categories ‒ mostly aneuploidy and still often idiopathic.

    Sturm J, Milera H, Essmann S, et al.

    Journal of perinatal medicine 2022; (50(7)):985-992 doi:10.1515/jpm-2022-0005.

    PMID: 35405041
  7. 7

    RASopathies are the most common set of monogenic syndromes identified by exome sequencing for nonimmune hydrops fetalis: A systematic review and meta-analysis.

    Makhamreh MM, Shivashankar K, Araji S, et al.

    American journal of medical genetics. Part A 2024; (194(5)):e63494 doi:10.1002/ajmg.a.63494.

    PMID: 38156365
  8. 8

    Progressive non-immune hydrops fetalis associated with RASA1 mutation: prenatal imaging and genomic insights.

    Borthakur K, Mali N, Borthakur I

    BMJ case reports 2026; (19(2)) doi:10.1136/bcr-2025-270831.

    PMID: 41763666
  9. 9

    Prenatal screening tests and prevalence of fetal aneuploidies in a tertiary hospital in Thailand.

    Wongkrajang P, Jittikoon J, Sangroongruangsri S, et al.

    PloS one 2023; (18(4)):e0284829 doi:10.1371/journal.pone.0284829.

    PMID: 37079630
  10. 10

    Factors associated with test failure in pregnant women undergoing cell-free DNA-based testing for fetal trisomy.

    Chang J, Qi Q, Zhou X, et al.

    Journal of medical screening 2021; (28(4)):411-418 doi:10.1177/09691413211009940.

    PMID: 33884933
  11. 11

    Prenatal hydrops fetalis associated with infantile free sialic acid storage disease due to a novel homozygous deletion in the SLC17A5 gene.

    Hasnain A, Burnett S, Agatep R, et al.

    Cold Spring Harbor molecular case studies 2021; (7(5)) doi:10.1101/mcs.a006106.

    PMID: 34667062
  12. 12

    Diagnostic yield from prenatal exome sequencing for non-immune hydrops fetalis: A systematic review and meta-analysis.

    Al-Kouatly HB, Shivashankar K, Mossayebi MH, et al.

    Clinical genetics 2023; (103(5)):503-512 doi:10.1111/cge.14309.

    PMID: 36757664
  13. 13

    The Evolution and Applications of Molecular Diagnostics in Veterinary and Clinical Medicine: From Traditional Methods to Emerging Technologies.

    Naveed A

    Molecular biotechnology 2025; doi:10.1007/s12033-025-01530-5.

    PMID: 41249772
  14. 14

    Application of Digital PCR in Detecting Human Diseases Associated Gene Mutation.

    Tong Y, Shen S, Jiang H, Chen Z

    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2017; (43(4)):1718-1730 doi:10.1159/000484035.

    PMID: 29130947
  15. 15

    Genetic disorders and pregnancy outcomes of non-immune hydrops fetalis in a tertiary referral center.

    Guo D, He S, Lin N, et al.

    BMC medical genomics 2023; (16(1)):83 doi:10.1186/s12920-023-01505-y.

    PMID: 37081464
  16. 16

    Utility of chromosomal microarray for diagnosis in cases of nonimmune hydrops fetalis.

    Mardy AH, Rangwala N, Hernandez-Cruz Y, et al.

    Prenatal diagnosis 2020; (40(4)):492-496 doi:10.1002/pd.5617.

    PMID: 31981373
  17. 17

    Confirmation of etiology in fetal hydrops by sonographic evaluation of fluid allocation patterns.

    Hartge DR, Weichert J, Gembicki M, Krapp M

    European journal of obstetrics, gynecology, and reproductive biology 2015; (195()):128-132 doi:10.1016/j.ejogrb.2015.09.006.

    PMID: 26540593
  18. 18

    A de novo homozygous missense mutation of the GUSB gene leads to mucopolysaccharidosis type VII identification in a family with twice adverse pregnancy outcomes due to non-immune hydrops fetalis.

    Du R, Tian H, Zhao B, et al.

    Molecular genetics and metabolism reports 2024; (38()):101033 doi:10.1016/j.ymgmr.2023.101033.

    PMID: 38149215
  19. 19

    Next Generation Sequencing after Invasive Prenatal Testing in Fetuses with Congenital Malformations: Prenatal or Neonatal Investigation.

    Emms A, Castleman J, Allen S, et al.

    Genes 2022; (13(9)) doi:10.3390/genes13091517.

    PMID: 36140685
  20. 20

    Evolving fetal phenotypes and clinical impact of progressive prenatal exome sequencing pathways: cohort study.

    Mone F, Abu Subieh H, Doyle S, et al.

    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2022; (59(6)):723-730 doi:10.1002/uog.24842.

    PMID: 34940998
  21. 21

    Rapid whole exome sequencing in pregnancies to identify the underlying genetic cause in fetuses with congenital anomalies detected by ultrasound imaging.

    Deden C, Neveling K, Zafeiropopoulou D, et al.

    Prenatal diagnosis 2020; (40(8)):972-983 doi:10.1002/pd.5717.

    PMID: 32333414
  22. 22

    Antenatal shunting and outcomes in fetuses with non-immune hydrops fetalis.

    Fragala V, Sabale S, Ashoor G, et al.

    Journal of perinatal medicine 2025; doi:10.1515/jpm-2025-0198.

    PMID: 40851234
  23. 23

    Extracorporeal life support for nonimmune hydrops fetalis.

    Witt RG, Raff GW, Gundy JV, Si MS

    Journal of pediatric intensive care 2012; (1(4)):207-210 doi:10.3233/PIC-12034.

    PMID: 31214410
  24. 24

    Clinical Course and Outcome of Non-Immune Fetal Hydrops in Singleton Pregnancies.

    Reischer T, Muth B, Catic A, et al.

    Journal of clinical medicine 2022; (11(3)) doi:10.3390/jcm11030702.

    PMID: 35160154
  25. 25

    Resolving fetal hydrops - A rare entity.

    Saxena D, Tiwari AK, Prasad R, Srivastav S

    European journal of medical genetics 2023; (66(12)):104888 doi:10.1016/j.ejmg.2023.104888.

    PMID: 37993095

This page explains the role of amniocentesis in diagnosing hydrops fetalis for educational purposes. It does not replace professional medical advice from your maternal-fetal medicine specialist or genetic counselor.

Get notified when new evidence is published on Non-immune hydrops fetalis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.